SAN DIEGO, Calif., June 10 /PRNewswire-FirstCall/ -- Protein Polymer
Technologies, Inc. (OTC Bulletin Board: PPTI), a San Diego-based biotechnology
company that is a pioneer in protein design and synthesis, announced today
that it has chosen Creative Public Relations as its agency of record for
corporate communications and investor relations programs.  The account team,
which will be led by Carole Boucard, director of account services and Bryan
deCastro, has nearly ten years of experience in the biotechnology industry.
    "We were impressed with Creative Public Relations ability to understand
our business and culture.  They proved to us that they have the expertise and
enthusiasm to help build our brand awareness, as well as increase visibility
among key audiences," said William N. Plamondon III, PPTI's Chief Executive
Officer.
    Creative Public Relations will be responsible for developing and
implementing PPTI's corporate communications initiatives, which will include
strategic corporate positioning, media relations, investor relations, as well
as product and service launches.  PPTI's new generation of biomaterials
includes products for use in spinal disc repair, female stress urinary
incontinence, surgical sealants for use in lung, bowel and cardiovascular
surgery, and dermal augmentation products for use in cosmetic procedures.

    About Protein Polymer Technologies
    Protein Polymer Technologies, Inc., is a San Diego-based company focused
on developing bioactive products to improve medical and surgical outcomes.
From its inception in 1988, PPTI has been a pioneer in protein design and
synthesis, developing an extensive portfolio of proprietary biomaterials.
These genetically engineered biomaterials are high molecular weight proteins,
processed into products with physical and biological characteristics tailored
to specific clinical performance requirements.  These protein polymers contain
no human or animal components that could potentially transmit or cause
disease.  Targeted products include dermal augmentation products for cosmetic
and reconstructive surgery, urethral bulking agents for the treatment of
stress urinary incontinence, surgical adhesives and sealants, scaffolds for
wound healing and tissue engineering, and depots for local drug delivery.
    To date, PPTI has been issued twenty-six U.S. Patents on its core
technology with corresponding issued and pending patents in key international
markets.

    About Creative Public Relations
    Creative Public Relations is a full service public relations and marketing
services firm based in Plantation, Florida.  Public Relations services include
media relations, promotions, strategic partnerships, corporate communications
and investor relations.

    This press release contains forward-looking statements that are based on
management's views and expectations.  Actual results could differ materially
from those expressed here; further, the Company is not obligated to comment
specifically on those differences.  Risks associated with the Company's
activities include raising adequate capital to continue operations scientific
and product development uncertainties, competitive products and approaches,
continuing collaborative partnership interest and funding, regulatory testing
and approvals, and manufacturing scale up.  The reader is encouraged to refer
to the Company's 2004 Annual Report Form 10-KSB, and 10KSB/A and other recent
filings with the Securities and Exchange Commission, copies of which are
available from the Company, to further ascertain the risks associated with the
above statements.

Link to this page: